Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.
Department of Biotechnology, Jamia Millia Islamia, New Delhi 110025, India.
Exp Neurol. 2020 Dec;334:113464. doi: 10.1016/j.expneurol.2020.113464. Epub 2020 Sep 15.
Neuroinflammation is one of the most common etiology in various neurological disorders and responsible for multi-array neurotoxic manifestations such as neurodegeneration, neurotransmitters alteration and cognitive dysfunction. NR (Nerolidol) is a natural bioactive molecule which possesses significant antioxidant and anti-inflammatory potential, but suffers from glitches of low solubility, low bioavailability and fast hepatic metabolism. In the current study, we fabricated nano-engineered lipid carrier of nerolidol (NR-NLC) for its effective delivery into the brain and explored its effect on neuroinflammation, neurotransmitters level and on dysfunctional behavioral attributes induced by CYC (cyclophosphamide). The binding affinity of nerolidol with NLRP3 and TLR-4 was performed which showed stong interaction between them. NR-NLC was prepared by the ultrasonication methods and particle size was determined by Zeta-sizer. Swiss Albino mice were divided into 5 groups (n = 6), assessed for behavioral dysfunction, and sacrificed on the fifteenth day following cyclophosphamide treatment. Brains were then removed and used for biochemical, histopathological, immunohistochemical and fluorescence microscopic analysis. Biochemical analysis showed increased levels of MDA, TNF-α, IL-6, IL-1β, acetylcholine esterase, BDNF, 5-HT and dopamine, and reduced levels of SOD, CAT, GSH, IL-10, along with significant behavioral dysfunction in cyclophosphamide-treated animals. Significant neuronal damage was also observed in the histological study. Immunohistochemical analysis demonstrated increased expression of NLRP3 and caspase-1. Fluorescence microscopic analysis showed significant availability of NR-NLC in the hippocampus and cortex region. In contrast, treatment with NR-NLC effectively mitigated the aforementioned neurotoxic manifestation as compared to NR suspension. Our results showed potent neuroprotective effect of NR-NLC via modulation of oxidative stress, NLRP3 inflammasome, caspase-1 and neurotransmitter status.
神经炎症是各种神经紊乱中最常见的病因之一,负责多种神经毒性表现,如神经退行性变、神经递质改变和认知功能障碍。NR(橙花叔醇)是一种具有显著抗氧化和抗炎潜力的天然生物活性分子,但存在溶解度低、生物利用度低和快速肝代谢等缺陷。在本研究中,我们制备了橙花叔醇的纳米工程脂质载体(NR-NLC),用于其有效递送至大脑,并探讨了其对神经炎症、神经递质水平以及环磷酰胺(CYC)诱导的功能障碍行为特征的影响。进行了橙花叔醇与 NLRP3 和 TLR-4 的结合亲和力实验,结果表明它们之间存在强烈的相互作用。NR-NLC 通过超声处理方法制备,并通过 Zeta 粒径仪测定其粒径。将瑞士白化小鼠分为 5 组(每组 n=6),评估行为障碍,并在环磷酰胺处理后第 15 天处死。然后取出大脑,用于生化、组织病理学、免疫组织化学和荧光显微镜分析。生化分析显示,环磷酰胺处理的动物的 MDA、TNF-α、IL-6、IL-1β、乙酰胆碱酯酶、BDNF、5-HT 和多巴胺水平升高,SOD、CAT、GSH、IL-10 水平降低,同时行为功能明显障碍。组织学研究也观察到明显的神经元损伤。免疫组织化学分析显示 NLRP3 和 caspase-1 的表达增加。荧光显微镜分析显示 NR-NLC 在海马和皮质区域的显著可用性。相比之下,与 NR 混悬液相比,NR-NLC 的治疗有效减轻了上述神经毒性表现。我们的结果表明,NR-NLC 通过调节氧化应激、NLRP3 炎症小体、caspase-1 和神经递质状态,发挥强大的神经保护作用。